BRIEF published on 12/19/2025 at 07:35, 5 months 30 days ago Sensorion to Present at J.P. Morgan Healthcare Conference Biotechnology Gene Therapy J.P. Morgan Hearing Loss SENS-401
PRESS RELEASE published on 12/19/2025 at 07:30, 5 months 30 days ago Informations privilégiées / Autres communiqués Sensorion annonce sa participation à la 44ème conférence annuelle J.P. Morgan Healthcare Conference à San Francisco du 12 au 15 janvier 2026 pour présenter ses avancées en thérapies auditives Biotechnologie Conference J.P. Morgan Sensorion Thérapies Auditives
PRESS RELEASE published on 12/19/2025 at 07:30, 5 months 30 days ago Inside Information / Other news releases Sensorion to present at 44th Annual J.P. Morgan Healthcare Conference with focus on novel therapies for hearing loss disorders. CEO Nawal Ouzren to lead presentation Biotechnology Sensorion Hearing Loss Disorders J.P. Morgan Healthcare Conference Thérapies
BRIEF published on 09/17/2025 at 07:35, 9 months 1 day ago Sensorion announces its 2025 half-year results Funding Gene Therapy SENS-401 SENS-501 2025 Results
BRIEF published on 09/17/2025 at 07:35, 9 months 1 day ago Sensorion annonce ses résultats semestriels 2025 Financement Thérapie Génique SENS-401 SENS-501 Résultats 2025
PRESS RELEASE published on 09/17/2025 at 07:30, 9 months 1 day ago Inside Information / News release on accounts, results Sensorion reports 2025 half-year results, corporate update, and availability of half-year report. Progress in gene therapy programs for hearing loss disorders discussed Clinical Trials Gene Therapy Sensorion Hearing Loss Disorders 2025 Half-Year Results
PRESS RELEASE published on 09/17/2025 at 07:30, 9 months 1 day ago Informations privilégiées / Communiqué sur comptes, résultats Sensorion présente ses résultats du premier semestre 2025, activités de thérapie génique SENS-501, GJB2-GT et SENS-401, annonce dépôts réglementaires et études cliniques en cours Résultats Thérapie Génique Études Cliniques Dépôts Réglementaires Sensorion
BRIEF published on 09/04/2025 at 07:35, 9 months 14 days ago Sensorion présentera au 60e atelier sur la biologie de l'oreille interne Biotechnologie Thérapie Génique Sensorion Perte Auditive Atelier De Biologie De L'oreille Interne
BRIEF published on 09/04/2025 at 07:35, 9 months 14 days ago Sensorion to Present at 60th Inner Ear Biology Workshop Biotechnology Gene Therapy Sensorion Hearing Loss Inner Ear Biology Workshop
PRESS RELEASE published on 09/04/2025 at 07:30, 9 months 14 days ago Informations privilégiées / Autres communiqués Sensorion annonce sa participation à la 60ème conférence annuelle Inner Ear Biology Workshop pour présenter ses avancées en thérapie génique pour la perte auditive Thérapie Génique Sensorion Perte Auditive Biologie Oreille Interne 60ème Conférence
Published on 06/19/2026 at 04:30, 2 hours 54 minutes ago Uraniumx Discovery Corp. Announces Acquisition of Common Shares of Gold'n Futures Mineral Corp
Published on 06/19/2026 at 01:20, 6 hours 4 minutes ago American Hotel Income Properties REIT LP Reports Voting Results of Annual and Special Meeting
Published on 06/19/2026 at 01:07, 6 hours 17 minutes ago Usha Resources Announces Share Issuance in Payment of Debenture Interest, Adopts Semi-Annual Reporting
Published on 06/19/2026 at 00:00, 7 hours 24 minutes ago Redwood AI Announces Initiation of Chemical Risk Assessment Module
Published on 06/19/2026 at 07:00, 24 minutes ago HORNBACH Group delivers strong start to new financial year – net sales up 4.9% in Q1 2026/27
Published on 06/19/2026 at 06:59, 25 minutes ago Zehnder Group: Introduction of a divisional organizational structure
Published on 06/19/2026 at 06:00, 1 hour 24 minutes ago Hong Kong universities scale global heights, cementing education hub status
Published on 06/19/2026 at 03:35, 3 hours 49 minutes ago From Father's Day to Summer Getaways: How Oxygen Support Helps Protect Health During Europe's Peak Travel Season
Published on 06/18/2026 at 18:00, 13 hours 24 minutes ago Publication du nombre d’actions composant le capital et du nombre total de droits de vote au 31 mai 2026
Published on 06/18/2026 at 18:00, 13 hours 24 minutes ago Outstanding shares and voting rights statement at 31 May 2026
Published on 06/18/2026 at 17:45, 13 hours 39 minutes ago EURAZEO INVESTS IN LAURALU, A PAN-EUROPEAN PROVIDER OF DEPLOYABLE INDUSTRIAL INFRASTRUCTURE
Published on 06/18/2026 at 17:45, 13 hours 39 minutes ago EURAZEO INVESTIT DANS LAURALU, ACTEUR PANEUROPÉEN SPÉCIALISTE DES INFRASTRUCTURES INDUSTRIELLES DÉPLOYABLES
Published on 06/18/2026 at 17:45, 13 hours 39 minutes ago ASSEMBLEE GENERALE DU 16 JUIN 2026 : COMPTE-RENDU ET RESULTATS DES VOTES
